Global Obesity Market and Competitive Landscape – 2017

1. Obesity: Disease Overview

1.1. Obesity Symptoms

1.2. Obesity Etiology

1.3. Obesity Diagnosis

1.4. Obesity Treatment Options

2. Obesity Pipeline Insights

2.1. Obesity Phase 3 Clinical Trials

2.2. Obesity Phase 2 Clinical Trials

2.3. Obesity Phase 1 Clinical Trials

3. Obesity Epidemiology Analysis

4. US Obesity Market Insights

4.1. Marketed Products for Obesity in US

4.2. US Obesity Market Size & Forecast

4.3. US Obesity Product Sales Forecast

4.4. US Obesity Market Share Analysis

5. Germany Obesity Market Insights

5.1. Marketed Products for Obesity in Germany

5.2. Germany Obesity Market Size & Forecast

5.3. Germany Obesity Product Sales Forecast

5.4. Germany Obesity Market Share Analysis

6. France Obesity Market Insights

6.1. Marketed Products for Obesity in France

6.2. France Obesity Market Size & Forecast

6.3. France Obesity Product Sales Forecast

6.4. France Obesity Market Share Analysis

7. Italy Obesity Market Insights

7.1. Marketed Products for Obesity in Italy

7.2. Italy Obesity Market Size & Forecast

7.3. Italy Obesity Product Sales Forecast

7.4. Italy Obesity Market Share Analysis

8. Spain Obesity Market Insights

8.1. Marketed Products for Obesity in Spain

8.2. Spain Obesity Market Size & Forecast

8.3. Spain Obesity Product Sales Forecast

8.4. Spain Obesity Market Share Analysis

9. UK Obesity Market Insights

9.1. Marketed Products for Obesity in UK

9.2. UK Obesity Market Size & Forecast

9.3. UK Obesity Product Sales Forecast

9.4. UK Obesity Market Share Analysis

10. Europe Obesity Market Insights

10.1. Europe Obesity Market Size & Forecast

10.2. Europe Obesity Product Sales Forecast

10.3. Europe Obesity Market Share Analysis

11. Japan Obesity Market Insights

11.1. Marketed Products for Obesity in Japan

11.2. Japan Obesity Market Size & Forecast

11.3. Japan Obesity Product Sales Forecast

11.4. Japan Obesity Market Share Analysis

12. Global Obesity Market Insights

12.1. Global Obesity Market Size & Forecast

12.2. Global Obesity Product Sales Forecast

12.3. Global Obesity Market Share Analysis

13. Research Methodology

LIST OF TABLES

Table 1: Obesity Phase 3 Clinical Trials, Global, 2017

Table 2: Obesity Phase 2 Clinical Trials, Global, 2017

Table 3: Obesity Phase 1 Clinical Trials, Global, 2017

Table 4: Obesity Prevalence by G7 Countries, 2012 - 2021

Table 5: Marketed Products for Obesity in US, 2017

Table 6: US Obesity Market Size & Forecast ($mn), 2012 - 2021

Table 7: US Obesity Product Sales ($mn), 2012 - 2021

Table 8: US Obesity Market Trends, 2012 - 2021

Table 9: Marketed Products for Obesity in Germany, 2017

Table 10: Germany Obesity Market Size & Forecast ($mn), 2012 - 2021

Table 11: Germany Obesity Product Sales ($mn), 2012 - 2021

Table 12: Germany Obesity Market Trends, 2012 - 2021

Table 13: Marketed Products for Obesity in France, 2017

Table 14: France Obesity Market Size & Forecast ($mn), 2012 - 2021

Table 15: France Obesity Product Sales ($mn), 2012 - 2021

Table 16: France Obesity Market Trends, 2012 - 2021

Table 17: Marketed Products for Obesity in Italy, 2017

Table 18: Italy Obesity Market Size & Forecast ($mn), 2012 - 2021

Table 19: Italy Obesity Product Sales ($mn), 2012 - 2021

Table 20: Italy Obesity Market Trends, 2012 - 2021

Table 21: Marketed Products for Obesity in Spain, 2017

Table 22: Spain Obesity Market Size & Forecast ($mn), 2012 - 2021

Table 23: Spain Obesity Product Sales ($mn), 2012 - 2021

Table 24: Spain Obesity Market Trends, 2012 - 2021

Table 25: Marketed Products for Obesity in UK, 2017

Table 26: UK Obesity Market Size & Forecast ($mn), 2012 - 2021

Table 27: UK Obesity Product Sales ($mn), 2012 - 2021

Table 28: UK Obesity Market Trends, 2012 - 2021

Table 29: Europe Obesity Market Size & Forecast ($mn), 2012 - 2021

Table 30: Europe Obesity Product Sales ($mn), 2012 - 2021

Table 31: Marketed Products for Obesity in Japan, 2017

Table 32: Japan Obesity Market Size & Forecast ($mn), 2012 - 2021

Table 33: Japan Obesity Product Sales ($mn), 2012 - 2021

Table 34: Japan Obesity Market Trends, 2012 - 2021

Table 35: Global Obesity Market Size & Forecast ($mn), 2012 - 2021

Table 36: Global Obesity Product Sales ($mn), 2012 - 2021

LIST OF FIGURES

Figure 1: Obesity Pipeline by Phase (%), Global, 2017

Figure 2: Obesity Prevalence by G7 Countries, 2012 - 2021

Figure 3: US Obesity Market Size ($mn), 2012 - 2021

Figure 4: US Obesity Product Sales ($mn), 2012 - 2021

Figure 5: US Obesity Market Share by Products (%), 2016

Figure 6: US Obesity Market - Future Market Share (%), 2021

Figure 7: Germany Obesity Market Size ($mn), 2012 - 2021

Figure 8: Germany Obesity Product Sales ($mn), 2012 - 2021

Figure 9: Germany Obesity Market Share by Products (%), 2016

Figure 10: Germany Obesity Market - Future Market Share (%), 2021

Figure 11: France Obesity Market Size ($mn), 2012 - 2021

Figure 12: France Obesity Product Sales ($mn), 2012 - 2021

Figure 13: France Obesity Market Share by Products (%), 2016

Figure 14: France Obesity Market - Future Market Share (%), 2021

Figure 15: Italy Obesity Market Size ($mn), 2012 - 2021

Figure 16: Italy Obesity Product Sales ($mn), 2012 - 2021

Figure 17: Italy Obesity Market Share by Products (%), 2016

Figure 18: Italy Obesity Market - Future Market Share (%), 2021

Figure 19: Spain Obesity Market Size ($mn), 2012 - 2021

Figure 20: Spain Obesity Product Sales ($mn), 2012 - 2021

Figure 21: Spain Obesity Market Share by Products (%), 2016

Figure 22: Spain Obesity Market - Future Market Share (%), 2021

Figure 23: UK Obesity Market Size ($mn), 2012 - 2021

Figure 24: UK Obesity Product Sales ($mn), 2012 - 2021

Figure 25: UK Obesity Market Share by Products (%), 2016

Figure 26: UK Obesity Market - Future Market Share (%), 2021

Figure 27: Europe Obesity Market Size ($mn), 2012 - 2021

Figure 28: Europe Obesity Product Sales ($mn), 2012 - 2021

Figure 29: Europe Obesity Market Share by Products (%), 2016

Figure 30: Europe Obesity Market - Future Market Share (%), 2021

Figure 31: Japan Obesity Market Size ($mn), 2012 - 2021

Figure 32: Japan Obesity Product Sales ($mn), 2012 - 2021

Figure 33: Japan Obesity Market Share by Products (%), 2016

Figure 34: Japan Obesity Market - Future Market Share (%), 2021

Figure 35: Global Obesity Market Size ($mn), 2012 - 2021

Figure 36: Global Obesity Product Sales ($mn), 2012 - 2021

Figure 37: Global Obesity Market Share by Products (%), 2016

Figure 38: Global Obesity Market - Future Market Share (%), 2021

Global Obesity Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Obesity Market and Competitive Landscape – 2017, provides comprehensive insights into Obesity pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Obesity market size and drug sales. This research also provides insights into Obesity epidemiology and late stage pipeline.
The report is classified into twelve sections – Obesity overview with definitions, symptoms, etiology, diagnosis, treatment options; Obesity pipeline insights covering late stage clinical trials pipeline; Obesity prevalence trends by countries; Obesity market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

• Obesity pipeline: Find out the drugs in clinical trials for Obesity by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Obesity epidemiology: Find out the prevalence of Obesity by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
• Obesity products: Identify key products marketed and prescribed for Obesity by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
• Obesity market size: Find out the market size for Obesity drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
• Obesity drug sales: Find out the sales of Obesity drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
• Obesity drugs sales forecast: Sales forecast for Obesity drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
• Obesity market share analysis: Find out the market shares of Obesity drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

• Evaluate commercial market opportunities for Obesity drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in Obesity market
• Develop in-depth knowledge of competition and markets
• Analyze sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track market trends and analyze key events in Obesity market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies